Literature DB >> 15856148

[Rhabdomyolysis after administration of diclofenac].

K Knobloch1, D Rossner, T Gössling, A Lichtenberg, M Richter, C Krettek.   

Abstract

Rhabdomyolysis may develop after various traumatic and nontraumatic circumstances. The use of lipid-lowering statins as well as the abuse of stimulants such as methylendioxymethamphetamine (ecstasy) can lead to fatal rhabdomyolysis with acute renal failure. We describe a case of diclofenac-induced rhabdomyolysis after a cumulative dose of 200 mg per os with consecutive critical increase of the creatine kinase and myoglobin. Prescription of diclofenac should therefore be done with caution. In cases of emergent myalgias, immediate testing of creatine kinase and myoglobin is mandatory to exclude fatal rhabdomyolysis with acute renal failure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15856148     DOI: 10.1007/s00113-004-0874-z

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  11 in total

1.  A case of rhabdomyolysis accompanying acute renal failure secondary to weight lifting.

Authors:  O Baysal; H Taskapan; C Taskapan; E Kaya; I Sahin; H Kirimlioglu; N Karakas
Journal:  Clin Nephrol       Date:  2003-10       Impact factor: 0.975

2.  'Ecstasy' intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting.

Authors:  Ron Ben-Abraham; Oded Szold; Valery Rudick; Avi A Weinbroum
Journal:  Eur J Emerg Med       Date:  2003-12       Impact factor: 2.799

3.  Statin-associated rhabdomyolysis triggered by grapefruit consumption.

Authors:  Jens P Dreier; Matthias Endres
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

4.  Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin.

Authors:  A Juhani Kahri; Miia M Valkonen; Matti K E Vuoristo; Pertti J Pentikäinen
Journal:  Ann Pharmacother       Date:  2004-02-13       Impact factor: 3.154

5.  Two cases of exertional rhabdomyolysis precipitated by personal trainers.

Authors:  Brian L Springer; Priscilla M Clarkson
Journal:  Med Sci Sports Exerc       Date:  2003-09       Impact factor: 5.411

6.  Case report: diclofenac-induced rhabdomyolysis.

Authors:  F G Delrio; Y Park; B Herzlich; D Grob
Journal:  Am J Med Sci       Date:  1996-08       Impact factor: 2.378

Review 7.  Crush injury and rhabdomyolysis.

Authors:  Darren J Malinoski; Matthew S Slater; Richard J Mullins
Journal:  Crit Care Clin       Date:  2004-01       Impact factor: 3.598

8.  Rhabdomyolysis induced by a single dose of a statin.

Authors:  S Jamil; P Iqbal
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

9.  A case of rhabdomyolysis with fatal outcome after a treatment with levofloxacin.

Authors:  Fabrice Petitjeans; Julien Nadaud; Jean Paul Perez; Bruno Debien; Frederic Olive; Thierry Villevieille; Bruno Pats
Journal:  Eur J Clin Pharmacol       Date:  2003-10-24       Impact factor: 2.953

10.  Etiology and frequency of rhabdomyolysis.

Authors:  Corri Black; Hershel Jick
Journal:  Pharmacotherapy       Date:  2002-12       Impact factor: 4.705

View more
  6 in total

1.  Severe rhabdomyolysis caused by Plasmodium vivax malaria in the Brazilian Amazon.

Authors:  André M Siqueira; Márcia A A Alexandre; Maria P G Mourão; Valquir S Santos; Suely K Nagahashi-Marie; Maria G C Alecrim; Marcus V G Lacerda
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

2.  Single-dose-dexketoprofen-induced acute kidney injury due to massive rhabdomyolysis.

Authors:  Tansu Sav; Aydin Unal; Abdulsamet Erden; Ali Ihsan Gunal
Journal:  Int Urol Nephrol       Date:  2011-05-07       Impact factor: 2.370

3.  Meloxicam-induced rhabdomyolysis in the context of an acute ross river viral infection.

Authors:  Mahmood Al Kindi; Vidya Limaye; Pravin Hissaria
Journal:  Allergy Asthma Immunol Res       Date:  2011-11-10       Impact factor: 5.764

Review 4.  Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction.

Authors:  Yusuf Haydar Ertekin; Burkay Yakar; Hülya Ertekin; Ayşegül Uludağ; Murat Tekin
Journal:  Drug Saf Case Rep       Date:  2015-12

5.  Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database.

Authors:  Mulugeta Russom; Yodit Fitsum; Abiel Abraham; Ruth L Savage
Journal:  Drugs Real World Outcomes       Date:  2021-03-30

6.  Diclofenac Concentrations in Post-Mortem Specimens-Distribution, Case Reports, and Validated Method (UHPLC-QqQ-MS/MS) for Its Determination.

Authors:  Paweł Szpot; Olga Wachełko; Marcin Zawadzki
Journal:  Toxics       Date:  2022-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.